...potential targets.The company is one of at least three pursuing therapeutic RNA editing. Last November, Shape Therapeutics Inc....

...guide that binds a target RNA sequence and recruits adenosine deaminases acting on RNA (ADARs), Shape Therapeutics Inc.’s...

...Shape raises $35.5M A round RNA editing company Shape Therapeutics Inc. raised $35.5 million in a series A...

...HER4) (ErbB4) Epidermal growth factor receptor (EGFR) (ErbB1) (HER1) Epidermal growth factor receptor 2 (HER2) (EGFR2) (ErbB2) (neu) CD19 Kallikrein Shape Therapeutics Inc....